Moleculin Biotech, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-9.8M | $-3.9M |
| Depreciation & Amortization | $18.0K | $6.0K |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | $707.0K | $324.0K |
| Net Cash from Operating Activities | $-7.3M | $-3.8M |
| Investing Activities | ||
| Capital Expenditures | $28.0K | $21.0K |
| Business Acquisitions | $0 | $100.0K |
| Net Cash from Investing Activities | $-28.0K | $-121.0K |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $10.1M | $8.9M |
| Net Change in Cash | $2.7M | $5.0M |
| Free Cash Flow | $-7.4M | $-3.8M |